The Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class ...
Dr. Will Bulsiewicz explains the importance of spacing meals apart to improve gut health, enhance digestion, and align with natural body rhythms.
While Novo Nordisk's Ozempic is the most mainstream GLP-1 medication, Eli Lilly (NYSE: LLY) has two blockbuster weight loss ...
With with GLP-1 drugs, gastrointestinal issues, such as nausea, vomiting, constipation, and gastroesophageal reflux disease, ...
A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.
Underrepresentation of women as participants and researchers in CV clinical trials remains a problem, asserts a review ...
Oprah Winfrey is sparking a debate around weight, willpower and perception after the media mogul revealed her perceptions ...
For people with diabetes, the use of GLP-1 RAs is associated with reduced risk for certain disorders and conditions.
With respect to risks, GLP-1RA use was significantly associated with an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, drug-induced pancreatitis, and other ...
Websites that sell compounded glucagon-like peptide-1 receptor agonists (GLP-1 RAs) often partially inform or misinform consumers, including with respect to US Food and Drug Administration approval.
Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...
The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...